Microbiology of early CF lung disease - PubMed (original) (raw)
Microbiology of early CF lung disease
Lisa Saiman. Paediatr Respir Rev. 2004.
Abstract
Recent bronchoscopy studies using assays to measure inflammation and molecular typing techniques have facilitated an increased understanding of the early events that occur within the lungs of young children with cystic fibrosis and provided additional insights into the natural history of lung disease in children. In 2000, the US CF National Patient Registry data showed that among 1000 infants <2 years of age, the first bacterial pathogens detected are Haemophilus influenzae, Staphylococcus aureus, and Pseudomonas aeruginosa and the prevalence of these pathogens in these young infants are 19%, 42%, and 29%, respectively. In addition, 7% harbour Stenotrophomonas maltophilia and <1% harbour Burkholderia cepacia complex. Several investigators have performed bronchoscopy studies on young infants to further examine the natural history of lung disease. In one such study of 40 CF infants, 65%, 63% and 70% of children at 1, 2, and 3 years of age harboured at least one CF pathogen. H. influenzae was most common (38%) in infants at 1 year of age, and S. aureus was most common in 2 (37%) and 3 (36%) year olds. P. aeruginosa increased from 18% at 1 year of age to 33% at 3 years of age and was usually present in high numbers, i.e., > or =10(5) CFU/ml of BAL fluid. Investigators have studied the microbiology of young CF infants using specimens derived from the upper airway (deep throat) compared with the lower airway (broncheoalveolar lavage specimens) to determine if the upper airway is predictive of pathogens in the lower airway. In general, these studies have shown that a negative oropharyngeal culture indicated that isolation of P. aeruginosa from the lower airway was unlikely, but a positive culture did not predict lower airway infection. Similar findings were noted for H. influenzae and S. aureus.
Similar articles
- Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
Jain K, Wainwright C, Smyth AR. Jain K, et al. Cochrane Database Syst Rev. 2013 Dec 23;(12):CD009530. doi: 10.1002/14651858.CD009530.pub2. Cochrane Database Syst Rev. 2013. PMID: 24363033 Updated. Review. - Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis.
Armstrong DS, Grimwood K, Carlin JB, Carzino R, Olinsky A, Phelan PD. Armstrong DS, et al. Pediatr Pulmonol. 1996 May;21(5):267-75. doi: 10.1002/(SICI)1099-0496(199605)21:5<267::AID-PPUL1>3.0.CO;2-K. Pediatr Pulmonol. 1996. PMID: 8726151 - Induced sputum compared to bronchoalveolar lavage in young, non-expectorating cystic fibrosis children.
Blau H, Linnane B, Carzino R, Tannenbaum EL, Skoric B, Robinson PJ, Robertson C, Ranganathan SC. Blau H, et al. J Cyst Fibros. 2014 Jan;13(1):106-10. doi: 10.1016/j.jcf.2013.05.013. Epub 2013 Jun 24. J Cyst Fibros. 2014. PMID: 23806622 Clinical Trial. - Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis.
Sagel SD, Gibson RL, Emerson J, McNamara S, Burns JL, Wagener JS, Ramsey BW; Inhaled Tobramycin in Young Children Study Group; Cystic Fibrosis Foundation Therapeutics Development Network. Sagel SD, et al. J Pediatr. 2009 Feb;154(2):183-8. doi: 10.1016/j.jpeds.2008.08.001. Epub 2008 Sep 25. J Pediatr. 2009. PMID: 18822427 Free PMC article. - Disease surveillance using bronchoalveolar lavage.
Brennan S, Gangell C, Wainwright C, Sly PD. Brennan S, et al. Paediatr Respir Rev. 2008 Sep;9(3):151-9. doi: 10.1016/j.prrv.2008.01.002. Epub 2008 Jul 30. Paediatr Respir Rev. 2008. PMID: 18694706 Review.
Cited by
- Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients.
Cox MJ, Allgaier M, Taylor B, Baek MS, Huang YJ, Daly RA, Karaoz U, Andersen GL, Brown R, Fujimura KE, Wu B, Tran D, Koff J, Kleinhenz ME, Nielson D, Brodie EL, Lynch SV. Cox MJ, et al. PLoS One. 2010 Jun 23;5(6):e11044. doi: 10.1371/journal.pone.0011044. PLoS One. 2010. PMID: 20585638 Free PMC article. - True microbiota involved in chronic lung infection of cystic fibrosis patients found by culturing and 16S rRNA gene analysis.
Rudkjøbing VB, Thomsen TR, Alhede M, Kragh KN, Nielsen PH, Johansen UR, Givskov M, Høiby N, Bjarnsholt T. Rudkjøbing VB, et al. J Clin Microbiol. 2011 Dec;49(12):4352-5. doi: 10.1128/JCM.06092-11. Epub 2011 Oct 19. J Clin Microbiol. 2011. PMID: 22012018 Free PMC article. - Reliability of quantitative real-time PCR for bacterial detection in cystic fibrosis airway specimens.
Zemanick ET, Wagner BD, Sagel SD, Stevens MJ, Accurso FJ, Harris JK. Zemanick ET, et al. PLoS One. 2010 Nov 30;5(11):e15101. doi: 10.1371/journal.pone.0015101. PLoS One. 2010. PMID: 21152087 Free PMC article. - Cystic fibrosis: benefits and clinical outcome.
McKay KO. McKay KO. J Inherit Metab Dis. 2007 Aug;30(4):544-55. doi: 10.1007/s10545-007-0620-0. Epub 2007 Jul 6. J Inherit Metab Dis. 2007. PMID: 17619175 - Acute intratracheal Pseudomonas aeruginosa infection in cystic fibrosis mice is age-independent.
Munder A, Wölbeling F, Kerber-Momot T, Wedekind D, Baumann U, Gulbins E, Tümmler B. Munder A, et al. Respir Res. 2011 Nov 7;12(1):148. doi: 10.1186/1465-9921-12-148. Respir Res. 2011. PMID: 22059807 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical